- Home
- AMLX vs SIBN Comparison
AMLX vs SIBN Comparison
Compare AMLX & SIBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMLX
- SIBN
- Stock Information
- Founded
- AMLX 2014
- SIBN 2008
- Country
- AMLX United States
- SIBN United States
- Employees
- AMLX N/A
- SIBN N/A
- Industry
- AMLX Biotechnology: Pharmaceutical Preparations
- SIBN Medical/Dental Instruments
- Sector
- AMLX Health Care
- SIBN Health Care
- Exchange
- AMLX Nasdaq
- SIBN Nasdaq
- Market Cap
- AMLX 481.9M
- SIBN 547.3M
- IPO Year
- AMLX 2022
- SIBN 2018
- Fundamental
- Price
- AMLX $3.30
- SIBN $17.84
- Analyst Decision
- AMLX Buy
- SIBN Strong Buy
- Analyst Count
- AMLX 7
- SIBN 6
- Target Price
- AMLX $7.60
- SIBN $23.00
- AVG Volume (30 Days)
- AMLX 748.4K
- SIBN 326.8K
- Earning Date
- AMLX 03-04-2025
- SIBN 02-24-2025
- Dividend Yield
- AMLX N/A
- SIBN N/A
- EPS Growth
- AMLX N/A
- SIBN N/A
- EPS
- AMLX N/A
- SIBN N/A
- Revenue
- AMLX $196,485,000.00
- SIBN $157,035,000.00
- Revenue This Year
- AMLX N/A
- SIBN $21.89
- Revenue Next Year
- AMLX N/A
- SIBN $16.65
- P/E Ratio
- AMLX N/A
- SIBN N/A
- Revenue Growth
- AMLX N/A
- SIBN 18.98
- 52 Week Low
- AMLX $1.58
- SIBN $11.70
- 52 Week High
- AMLX $19.95
- SIBN $20.60
- Technical
- Relative Strength Index (RSI)
- AMLX 39.44
- SIBN 61.08
- Support Level
- AMLX $3.42
- SIBN $17.30
- Resistance Level
- AMLX $3.65
- SIBN $18.45
- Average True Range (ATR)
- AMLX 0.26
- SIBN 0.82
- MACD
- AMLX 0.00
- SIBN 0.00
- Stochastic Oscillator
- AMLX 2.94
- SIBN 74.58
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder.
About SIBN SI-BONE Inc.
SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.